Skip to content

Evaluation of Bone Healing Around Dental Implants Using Light Therapy With or Without Supplements

A Comparative Evaluation of Crestal Bone Levels Around Endosseous Implants with Photobiostimulation Alone and Photobiostimulation Combined with Calcium and Vitamin D3 Supplementation: A Cone Beam Computed Tomography-Based Randomized Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107919
Enrollment
30
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: PHOTOBIOSTIMULATION COMBINED WITH CALCIUM AND VITAMIN D3 SUPPLEMENTATION: Following implant placement, patients will be prescribed Shelcal 500 (containing 500 mg elemental calcium and 2
the tablet will be taken after meals, and patients will be instructed to take it at the same time each day if initiated in the morning, then consistently every morning for the entire 15-day course to

Sponsors

Dr Rohini Bhise
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Single missing anterior or posterior tooth with an adequate width and height of edentulous space available for the placement of implant. Systemically healthy patients ASA Grade I And II. Healed alveolar ridge ( at least 3 months after tooth extraction). Adjacent teeth intact , restored with functionally and aesthetically good restorations, restored with prosthesis precluding the addition of missing teeth.

Exclusion criteria

Exclusion criteria: Patients with systemic conditions affecting bone metabolism, such as diabetes mellitus, osteoporosis, malignancy, renal or liver dysfunction, endocrine disorders, or those receiving bisphosphonate therapy. Subjects with severe parafunctional habits. Pregnant or lactating subjects. Subjects unable to maintain oral hygiene procedures. Presence of pathologic condition in area intended for implant surgery. Subjects with tobacco habits, psychological problems, and unrealistic expectations about treatment. Patients undergoing or with a history of chemotherapy or radiotherapy. Patients on medications known to alter bone metabolism. Subjects not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
To evaluate changes in crestal bone levels around endosseous dental implants from baseline (immediately post-placement) to 3 months after prosthesis delivery, while accounting for physiologic bone remodelling expected in the first year of implant integrationTimepoint: at baseline and at six month follow up post implant placement or 3 months post prosthesis delivery

Secondary

MeasureTime frame
Bucco-lingual dimensional changes of the peri-implant alveolar boneTimepoint: at baseline and six months following dental implant placement;Peri-implant bone densityTimepoint: at baseline and six months following dental implant placement;Peri-implant Probing DepthTimepoint: at the time of prosthetic delivery and at the three-month follow-up;Modified Plaque IndexTimepoint: 2 weeks after placement of healing abutment before recording impression and at 3 months after prosthesis delivery

Countries

India

Contacts

Public ContactDr Raghavendra Metri

Maharashtra Institute of Dental Sciences and Research

drrohinibhise@gmail.com9158118232

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026